Cocrystal Pharma, Inc. — Director's Dealing 2020

Apr 27, 2020

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Cocrystal Pharma, Inc. (COCP)
CIK: 0001412486
Period of Report: 2020-04-15

Reporting Person: Kornberg Roger D. (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	477217	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$2.78	2028-09-21	Common Stock (150000)		Direct

Footnotes

F1: The stock options vest as follows: (i) 1/4 vested on September 21, 2019 and the remaining 3/4 vest in twelve equal quarterly installments on the last day of March, June, September, and December commencing December 31, 2019 and continuing through September 21, 2022, provided that the Reporting Person continues to be a consultant of the Issuer on each applicable vesting date.